Philip A. Band

Fundador en CytoDel LLC .

Health Technology

Perfil

Philip A.
Band is the founder.
He founded CytoDel LLC in 2012 and currently holds the title of Chief Executive Officer & Director.
In addition to his founding position, Dr. Band also held the position of Vice President-Research at Biomatrix, Inc.

Cargos activos de Philip A. Band

Empresas	Cargo	Inicio
CytoDel LLC CytoDel LLC BiotechnologyHealth Technology CytoDel LLC is engaged in biotechnology services. Its products include Ctyo-111, first botulism antidote and Cyto-012, musculoskeletal and aesthetic medicine. The company was founded by Philip A. Band, Konstantin Ichtchenko and Edwin Vazquez Cintron in 2012 and is headquartered in New York City, NY.	Fundador	01/01/2012

Todos los cargos activos de Philip A. Band

Antiguos cargos conocidos de Philip A. Band.

Empresas	Cargo	Fin
Biomatrix, Inc. Biomatrix, Inc. Pharmaceuticals: MajorHealth Technology Biomatrix, Inc. develops, manufactures, markets and sells a series of proprietary viscoelastic products called 'hylans'. Hylans are the second generation of viscoelastics used in medicine and are characterized by significantly enhanced physical properties such as elasticity, viscosity and pseudoplasticity. These products are used in therapeutic medical applications and skin care. The company was founded by Endre A. Balazs and Janet L. Denlinger in 1981 and is headquartered in Ridgefield, NJ.	Director Técnico/Científico/I+D	11/05/2011

Ver el detalle de la experiencia de Philip A. Band.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Philip A. Band.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Biomatrix, Inc. Biomatrix, Inc. Pharmaceuticals: MajorHealth Technology Biomatrix, Inc. develops, manufactures, markets and sells a series of proprietary viscoelastic products called 'hylans'. Hylans are the second generation of viscoelastics used in medicine and are characterized by significantly enhanced physical properties such as elasticity, viscosity and pseudoplasticity. These products are used in therapeutic medical applications and skin care. The company was founded by Endre A. Balazs and Janet L. Denlinger in 1981 and is headquartered in Ridgefield, NJ.	Health Technology
CytoDel LLC CytoDel LLC BiotechnologyHealth Technology CytoDel LLC is engaged in biotechnology services. Its products include Ctyo-111, first botulism antidote and Cyto-012, musculoskeletal and aesthetic medicine. The company was founded by Philip A. Band, Konstantin Ichtchenko and Edwin Vazquez Cintron in 2012 and is headquartered in New York City, NY.	Health Technology